Pharmacopeia Names Software Group Accelrys; NewUnittoOfferConsultingServices | GenomeWeb

Pharmacopeia has officially launched its software subsidiary, uniting Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and the Genetics Computer Group under the name of Accelrys.

The unit will begin operating under the new name on June 1.

Mike Stapleton, COO of the subsidiary, unveiled the name, structure, and objectives of Accelrys at the American Chemical Society meeting in San Diego on April 2. “Our vision is of an integrated software platform supporting enterprise-wide R&D decisions,” Stapleton said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.